Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes

European Journal of Pharmacology

Volumn 794, Issue , 2017, Pages 106-114

  Jin, Yingli ^a   Liu, Shuping ^a   Ma, Qingshan ^b   Xiao, Dong ^b   Chen, Li ^a  

^a JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

AMPK; Autophagy; Berberine; High glucose; Podocyte

Indexed keywords

BERBERINE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TARGET OF RAPAMYCIN KINASE;

ANIMAL; APOPTOSIS; AUTOPHAGY; CELL PROTECTION; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; METABOLISM; MOUSE; PHOSPHORYLATION; PODOCYTE; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; AUTOPHAGY; BERBERINE; CELL SURVIVAL; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GLUCOSE; MICE; PHOSPHORYLATION; PODOCYTES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84997285833     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.11.037     Document Type: Article

References (41)

1. Ai, F., et al. Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway. Int. J. Clin. Exp. Pathol. 8 (2015), 2509–2516.
2. Cai, X., Bao, L., Ren, J., Li, Y., Zhang, Z., Grape seed procyanidin B2 protects podocytes from high glucose-induced mitochondrial dysfunction and apoptosis via the AMPK-SIRT1-PGC-1α axis in vitro. Food Funct. 7 (2016), 805–815.
3. Chang, W., Chen, L., Hatch, G.M., Berberine as a therapy for type 2 diabetes and its complications: from mechanism of action to clinical studies. Biochem. Cell Biol. 1 (2014), 1–8.
4. Dokladny, K., Myers, O.B., Moseley, P.L., Heat shock response and autophagy-cooperation and control. Autophagy 11 (2015), 200–213.
5. Dong, C., et al. Heme oxygenase-1 enhances autophagy in podocytes as a protective mechanism against high glucose-induced apoptosis. Exp. Cell Res. 337 (2015), 146–159.
6. Eid, A.A., et al. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes 62 (2013), 2935–2947.
7. Fan, X., et al. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway. J. Transl. Med., 13, 2015, 92.
8. Guo, T., et al. Berberine ameliorates hepatic steatosis and suppresses liver and adipose tissue inflammation in mice with diet-induced obesity. Sci. Rep., 6, 2016, 2612.
9. Hao, M., et al. Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro. Eur. J. Pharmacol. 654 (2011), 320–325.
10. Inoki, K., mTOR signaling in autophagy regulation in the kidney. Semin. Nephrol. 34 (2014), 2–8.
11. Kandadi, M.R., et al. Deletion of protein tyrosine phosphatase 1B rescues against myocardial anomalies in high fat diet-induced obesity: role of AMPK-dependent autophagy. Biochim. Biophys. Acta 1852 (2015), 299–309.
12. Kim, J., Kundu, M., Viollet, B., Guan, K.L., AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13 (2011), 132–141.
13. Langer, S., Kreutz, R., Eisenreich, A., Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. J. Nephrol. 29 (2016), 765–773.
14. Lee, H.J., et al. Tadalafil integrates nitric oxide-hydrogen sulfide signaling to inhibit high glucose-induced matrix protein synthesis in podocytes. J. Biol. Chem. 290 (2015), 12014–12026.
15. Lee, K.H., Lo, H.L., Tang, W.C., Hsiao, H.H., Yang, P.M., A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine. Sci. Rep., 4, 2014, 6394.
16. Lee, Y.S., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55 (2006), 2256–2264.
17. Lenoir, O., et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. Autophagy 11 (2015), 1130–1145.
18. Lindqvist, L.M., Simon, A.K., Baehrecke, E.H., Current questions and possible controversies in autophagy. Cell Death Discov., 2015, 1.
19. Ma, T., et al. High glucose induces autophagy in podocytes. Exp. Cell Res. 319 (2013), 779–789.
20. Mora-Fernández, C., et al. Diabetic kidney disease: from physiology to therapeutics. J. Physiol. 592 (2014), 3997–4012.
21. Mundel, P., et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cells lines. Exp. Cell Res. 236 (1997), 248–258.
22. Pirillo, A., Catapano, A.L., Berberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studies. Atherosclerosis 243 (2015), 449–461.
23. Reidy, K., Kang, H.M., Hostetter, T., Susztak, K., Molecular mechanisms of diabetic kidney disease. J. Clin. Investig. 124 (2014), 2333–2340.
24. Roussel, R., Lorraine, J., Rodriguez, A., Salaun-Martin, C., Overview of data concerning the safe use of antihyperglycemic medications in type 2 diabetes mellitus and chronic kidney disease. Adv. Ther. 32 (2015), 1029–1064.
25. Siddiqi, F.S., et al. The histone methyltransferase enzyme enhancer of zeste homolog 2 protects against podocyte oxidative stress and renal injury in diabetes. J. Am. Soc. Nephrol., 2015, 2014090898.
26. Li, C., Siragy, H.M., (Pro)renin receptor regulates autophagy and apoptosis in podocytes exposed to high glucose. Am. J. Physiol. Endocrino. Metab. 309 (2015), E302–E310.
27. Stieger, N., Worthmann, K., Schiffer, M., The role of metabolic and haemodynamic factors in podocyte injury in diabetes. Diabetes Metab. Res. Rev. 27 (2011), 207–215.
28. Sun, S.F., et al. Renoprotective effect of berberine on type 2 diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 42 (2015), 662–670.
29. Vallon, V., Komers, R., Pathophysiology of the diabetic kidney. Compr. Physiol. 1 (2011), 1175–1232.
30. Wang, X.X., et al. G Protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J. Am. Soc. Nephrol. 27 (2016), 1362–1378.
31. Wei, M., Li, Z., Xiao, L., Yang, Z., Effects of ROS-relative NF-κB signaling on high glucose-induced TLR4 and MCP-1 expression in podocyte injury. Mol. Immunol. 68:2Pt A (2015), 261–271.
32. Wei, S., et al. Berberine attenuates development of the hepatic gluconeogenesis and lipid metabolism disorder in type 2 diabetic mice and in palmitate-incubated hepG2 cells through suppression of the HNF-4α miR122 pathway. PLoS One, 11, 2016, e0152097.
33. Xia, X., et al. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One, 6, 2011, e16556.
34. Xue, H., et al. HGSD attenuates neuronal apoptosis through enhancing neuronal autophagy in the brain of diabetic mice: the role of AMP-activated protein kinase. Life Sci. 3205 (2016), 30223–30225.
35. Yamahara, K., et al. The role of autophagy in the pathogenesis of diabetes nephropathy. J. Diabetes Res., 2013, 193757.
36. Yao, F., Zhang, M., Chen, L., 5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetesand diabetic complications. Acta Pharm. Sin. B 6 (2016), 20–25.
37. Yin, J., Gao, Z., Liu, D., Liu, Z., Ye, J., Berberine improves glucose metabolism through induction of glycolysis. Am. J. Physiol. Endocrinol. Metab. 294 (2008), E148–E156.
38. Yu, R., et al. Berberine-induced apoptotic and autophagic death of HepG2 cells requires AMPK activation. Cancer Cell Int., 14, 2014, 49.
39. Zeng, X.H., Zeng, X.J., Li, Y.Y., Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92 (2003), 173–176.
40. Zhang, M., et al. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis. Mol. Cell Endocrinol. 363 (2012), 122–130.
41. Zhang, M., et al. Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4. Mediat. Inflamm., 2013, 2013, 260464.